Athenex Pharmaceuticals (Chong Qing) Limited

Athenex Pharmaceuticals (Chong Qing) Limited is the headquarters of the U.S. Athenex Group in China.
Athenex Group was founded in 2003 and is headquartered in New York State, USA. It was successfully listed on the Nasdaq in the United States on June 14, 2017 (Nasdaq: ATNX). It is a pharmaceutical company engaged in research and production of innovative anti-tumor products, focusing on the R&D and commercialization of next-generation cancer treatment and supportive care. It has carried out multi-level business cooperation with world-class tumor research institutions such as Roswell Park Comprehensive Cancer Center, Upstate Medical University Cancer Center, and Johns Hopkins University. The Group has a leading medical technology innovation center and emerging manufacturing and supply chains spanning China and North America. The Group currently has obtained technology licenses and approved patents related to medical technology, and has more than 200 pending patent applications covering 66 countries, with huge market potential.
Huiyuan Pharmaceutical is located in Banan District, Chongqing, a place with beautiful mountains and clear waters. It plans to invest billions to build an intelligent and digital R&D and production base. Among them: the formulation plant covers an area of 500 mu; the API plant covers an area of 80 mu.
Relying on the Group's three oral formulation technology platforms, Orascovery, Mimetica, and OPAL, Huiyuan Pharmaceutical is committed to building a pharmaceutical innovation platform with independent intellectual property rights and core technologies. It will build an intelligent manufacturing system for oral solid and sterile formulations based on the modern Industry 4.0 level, with 8 formulation production lines. After completion, it will pass GMP audits in mainstream regulatory markets such as China, the United States, and Europe, and provide high-end anti-tumor formulations to the world. Athenex will surely become a world-class pharmaceutical company.
The purpose of Huiyuan Pharmaceutical is to improve the quality of life for patients and create value for customers.
Talent is the most valuable asset of an enterprise and an important undertaking of the company. To this end, we are looking for people with insight who are willing to grow actively with the team. We provide a highly advantageous development platform and growth environment.
For more details, please click: *